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Activation of inositol-requiring enzyme (IRE1a) is
an indispensable step in remedying the cellular
stress associated with lipid perturbation in the endo-
plasmic reticulum (ER) membrane. IRE1a is a single-
spanning ER transmembrane protein possessing
both kinase and endonuclease functions, and its
activation can be fully achieved through the dimer-
ization and/or oligomerization process. How IRE1a
senses membrane lipid saturation remains largely
unresolved. Using both computational and experi-
mental tools, we systematically investigated the
dimerization process of the transmembrane domain
(TMD) of IRE1a and found that, with help of the
serine 450 residue, the conserved tryptophan 457
residue buttresses the core dimerization interface
of IRE1a-TMD. BiFC (bimolecular fluorescence
complementation) experiments revealed that muta-
tion on these residues abolished the saturated fatty
acid-induced dimerization in the ER membrane and
subsequently inactivated IRE1a activity in vivo.
Therefore, our results suggest that the structural
elements of IRE1a-TMD serve as a key sensor that
detects membrane aberrancy.INTRODUCTION
The endoplasmic reticulum (ER) is a cellular compartment
responsible for protein folding, lipid synthesis, and calcium stor-
age. Physiological conditions such as elevated levels of free fatty
acids and glucose, oxidative stress, and inflammatory cytokines
are known to induce ER stress, leading to the accumulation ofThis is an open access article under the CC BY-Nunfolded or misfolded proteins or toxic lipid species (Wang
and Kaufman, 2012). Cellular adaptation to ER stress is achieved
through activation of the unfolded protein response (UPR), an in-
tegrated signal transduction pathway mediated by three ER
stress sensor proteins, IRE1 (inositol-requiring enzyme 1),
PERK (protein kinase R [PKR]-like ER kinase), and ATF6 (acti-
vating transcription factor 6) (Kaufman, 1999). UPR signaling
coordinates cellular responses by downregulating protein trans-
lation, enhancing the expression of ER chaperone proteins that
promote protein refolding, and activating proteases that are
involved in the degradation of misfolded proteins. When these
adaptive processes are insufficient to attenuate ER stress, the
UPR triggers apoptosis (Hetz and Papa, 2018; Wang and Kauf-
man, 2014).
Among the three UPR sensor proteins, IRE1a is the most
conserved protein and is ubiquitously expressed in cells.
IRE1a is a type I transmembrane protein with an N-terminal
luminal domain (LD) that acts as an ER stress sensor and a
C-terminal KEN (kinase-extension nuclease) domain containing
both Ser/Thr kinase and endoribonuclease activities (Kore-
nnykh and Walter, 2012). Under ER stress conditions, the LD
of IRE1a oligomerizes in the lumen, promoting self-association
of the protein (Oikawa et al., 2009). The dimerization of the
kinase domain (KD) facilitates trans-autophosphorylation, sub-
sequently activating the RNase domain (RD) (Ali et al., 2011).
The active form of IRE1a splices mRNA of the X-box binding
protein-1 (XBP1), producing the spliced XBP1 transcription fac-
tor (XBP1S) and thus resulting in the upregulation of genes
involved in enhancing ER protein-folding capacity and degrad-
ing unfolded or misfolded proteins (Lee et al., 2003; Yoshida
et al., 2001).
Dimerization of the LD or cytosolic domain is known to be
important for IRE1a activation, whereas dimerization of its
transmembrane domain (TMD) in the activation process re-
mains unclear. Hydrogen bonds and hydrophobic interactions
stabilize the dimerization interface of the LD, and disruptionCell Reports 27, 307–320, April 2, 2019 ª 2019 The Author(s). 307
C-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Figure 1. The Isolated IRE1a-TMD Dimerizes
in Both Synthetic and Cellular Membranes
(A) Fluorescence spectra of FITC- and TAMRA-
labeled TMD peptides inserted in POPC liposomes:
0.1 mol % of donor (FITC-TMD) or 0.1 mol % of
acceptor (TAMRA-TMD) peptide was reconstituted
in 400 mMof lipid. The spectra (excitation at 439 nm)
were measured for the samples containing the
donor and acceptor peptides (red), as well as con-
trol samples containing only the donor (black) and
only the acceptor (blue) peptides.
(B) Dependence of fluorescence energy transfer as
a function of the acceptor/lipid molar ratio. The ratio
of donor-labeled to acceptor-labeled peptides was
kept at 1, while the ratio of total peptide to lipid was
varied. The final concentration of the lipid was fixed
at 400 mM. The FRET efficiency was calculated as
described in STARMethods. Values are mean ± SD,
with n = 3.
(C) SDS-PAGE analysis of the IRE1a-TMD peptide.
The peptides dissolved in 13 lithium dodecyl sulfate
(LDS) sample loading buffer were loaded onto 9%
Bis-Tris gel. Bands were visualized using silver
staining.
(D) Top: TOXCAT assays. CAT activities from cells
expressing ToxR-TMD-MBP were quantified and
normalized to GpA-WT. GpA-WT and its disruptive
mutant (GpA-G83I) served as positive and negative controls, respectively. Values are mean ± SD, with n = 6. Bottom: western blotting analysis. The expression
levels of ToxR-TMD-MBP proteins were measured using anti-MBP antibody. The expression levels were also normalized to correct the CAT activity.
(E) MalE complementation assay. The TOXCAT chimeric proteins (ToxR-TMD-MBP) were plated on M9 agar containing 0.4%maltose. MalE activity was used to
show appropriate TMD topology.of these interactions prevents the self-association of the pro-
tein, subsequently reducing both the autophosphorylation and
the RNase activities of IRE1a (Li et al., 2010; Zhou et al.,
2006). In addition, mutations at the dimerization interface on
the KD diminish both the kinase and RNase activities (Ali
et al., 2011). Interestingly, a previous study suggested that
the IRE1a molecule lacking the LD is able to sense the lipid
perturbation in the membrane and contribute to IRE1a activa-
tion through the TMD (Volmer et al., 2013). Using a reporter
assay that detects its downstream factor, XBP1S, a follow-up
study concluded that generic sequence features of the
IRE1a-TMD are sufficient for sensing membrane aberrancy
(Kono et al., 2017). However, because of the dynamic and
complex nature of the UPR signaling network (Cho et al.,
2013; Tsuru et al., 2016; Yoshida et al., 2001), direct observa-
tion of the IRE1a-TMD conformation is required to establish
which features of the IRE1a-TMD are crucial for IRE1a activa-
tion as well as lipid saturation sensing.
In this study, we investigated how human IRE1a senses mem-
brane lipid saturation. To directly monitor the conformation of
IRE1a-TMD, we developed an in vivo BiFC (bimolecular fluores-
cence complementation) assay to confirm that lipid saturation
induces the dimerization of IRE1a-TMD in the ER membrane.
Systematic approaches using the in vivo BiFC assay and MD
simulations identified an essential residue, tryptophan 457,
which supports the core dimerization interface of IRE1a-TMD.
Our data reveal a key regulatory mechanism in which unique
structural features of the tryptophan residue modulate the satu-
rated fatty acid-induced dimerization of IRE1a-TMD and thus
promote an active conformation of IRE1a.308 Cell Reports 27, 307–320, April 2, 2019RESULTS
The Isolated TMD of IRE1a Dimerizes in Membranes
To assess whether the TMD of IRE1a dimerizes in the lipid
bilayer, we used an established Fo¨rster resonance energy
transfer (FRET) assay (Li et al., 2005) that measures the self-
association of TMD peptides in 1-palmitoyl 2-oleoyl phosphati-
dylcholine (POPC) liposomes. When both donor (fluorescein
isothiocyanate [FITC]) and acceptor (carboxytetramethylrhod-
amine [TAMRA]) labeled IRE1a-TMD peptides were present in
the POPC liposomes, we observed a decrease in the donor fluo-
rescence and an increased in the acceptor fluorescence, indi-
cating that FRET has occurred (Figure 1A). The observed FRET
values at various acceptor-to-lipid ratios (Figure 1B) were com-
parable with the previously measured TMD dimerization of
fibroblast growth factor receptor 3 (FGFR3) in the POPC lipo-
somes using the same dye pair (Li et al., 2005). This indicates
that the observed FRET in the IRE1a-TMD-containing liposomes
is not due entirely to random acceptor and donor colocalization
and that IRE1a-TMD has a propensity for self-association in
liposomes.
Two additional experiments further support our conclusion
that the IRE1a-TMD dimerizes and/or oligomerizes in the lipid
bilayer. First, SDS-PAGE analysis, which is commonly used to
detect the oligomerization status of TMDs, showed that the
IRE1a-TMD peptide has several oligomeric states, as evident
by the higher band (Figure 1C). The monomeric and dimeric
states did not separate clearly, possibly reflecting the dynamic
equilibrium between the two states during the electrophoresis,
which is frequently observed in short TMD peptides (Ng and
Deber, 2010). Second, the results of a TOXCAT assay, in which
association between the TMDs in the inner membrane of
E. coli drives expression of the reporter gene chloramphenicol
acetyltransferase (CAT) (Russ and Engelman, 1999), suggested
dimerization of the IRE1a-TMD peptides in the cellular mem-
brane. CAT activity was normalized to a positive control (the
TMD of glycophorin A [GpA]), which is known to dimerize
strongly, while GpA-G83I served as a dimerization-impaired
mutant (a negative control) (Lemmon et al., 1992). The CAT activ-
ity of IRE1a-TMD was significantly higher than the negative
control (Figure 1D), indicating that the IRE1a-TMD dimerizes in
a biological membrane. Furthermore, MalE complementation
assay showed that the lack of a TMD did not allow E. coli to
grow on maltose, whereas all other constructs exhibited robust
growth. This indicates that the maltose-binding protein (MBP)
domain of these fusion proteins was localized on the periplasm
of the NT326 cells, and the IRE1a-TMD was correctly inserted
in the cell membrane (Figure 1E). Therefore, we showed that
the isolated TMD of the IRE1a protein dimerizes and/or oligo-
merizes in lipid bilayers.
Both Trp457 and Ser450 Support Palmitate-Activated
Dimerization of the IRE1a-DLD In Vivo
Membrane lipid saturation induced by a saturated fatty acid,
palmitate, is known to upregulate the IRE1a activity (Kitai et al.,
2013; Volmer et al., 2013). In contrast to the conventional UPR
activation initiated by accumulation of unfolded protein in the
ER lumen, membrane lipid saturation did not trigger the clus-
tering of IRE1a proteins via oligomerization of the LD, and thus
palmitate is thought to use a different mechanism of activating
the IRE1a protein (Kitai et al., 2013). In addition, the IRE1a pro-
tein lacking the LD (30–407 aa, denoted as IRE1a-DLD) can be
activated by palmitate (Volmer et al., 2013), suggesting that
palmitate could directly regulate the conformation of IRE1a-
TMD. To directly monitor palmitate-induced dimerization in vivo,
we used a BiFC assay that has been successfully used to quan-
tify dimerization of both the seven TMD (7TM) receptor and the
receptor tyrosine kinases (RTKs) family proteins in vivo (Kosel
et al., 2010; Tao and Maruyama, 2008). Therefore, to dissect
the role of palmitate on the dimerization of IRE1a-TMD, we
used the IRE1a-DLD construct devoid of the upstream signal
(Volmer et al., 2013). The N-terminal Venus fragment (Myc-
tagged VN) and the C-terminal Venus fragment (HA-tagged
VC) were inserted downstream of the signal peptide (1–18 aa)
on the IRE1a-DLD (Figure 2A) (Shyu et al., 2006). Once both
VN-IRE1a-DLD and VC-IRE1a-DLD are in close proximity in
the ER membrane, the Venus fragments will be able to reconsti-
tute a native and fluorescent protein (Figure 2B).
We monitored the early response of palmitate-induced
dimerization of IRE1a-DLD in the IRE1a/ mouse embryonic
fibroblast (MEF) cells expressing both VN-IRE1a-DLD and VC-
IRE1a-DLD. IRE1a/ MEF cells have a negligible amount of
endogenous IRE1a proteins (Volmer et al., 2013) and thus allow
the monitoring of the dimerization efficiency of exogenously
expressing IRE1 variants in vivo. We first confirmed that the
expression levels of IRE1a-DLD in BSA- and palmitate-treated
IRE1a/ MEF cells were comparable with the endogenous
IRE1a levels in its parental MEF-WT cells (Figures S1A andS1B). Consistent with this, the exogenous expression of
IRE1a-DLD did not alter the palmitate-induced activation of
endogenous eIF2a, a subsequent downstream factor of the
other UPR sensor PERK (Figures S1C and S1D), demonstrating
that the PERK pathway was not perturbed by exogenously ex-
pressing the IRE1a-DLD proteins. In contrast, upon palmitate
treatment at 2 h, the Venus fluorescence intensity increased
significantly compared with the BSA-treated control cells (Fig-
ures 2C and 2D), indicating the reconstitution of the Venus fluo-
rescent protein and thus dimerization of the VN-IRE1a-DLD-WT
and VC-IRE1a-DLD-WT proteins.
Several lines of evidence suggest that the observed dimeriza-
tion of IRE1a-DLD in the in vivo BiFC assay was specifically
induced by palmitate. First, the IRE1a-DLD proteins were ex-
pressed at similar levels in both the BSA- and palmitate-treated
cells (Figures 2E, S1A, and S1B), suggesting that the enhanced
dimer formation of IRE1a-DLD by palmitate is not due to a differ-
ence in the protein expression levels between the two conditions.
Second, the palmitate-induced dimerization of IRE1a-DLD-WT
was further corroborated by the enhanced XBP1 splicing effi-
ciency (Figures 2F and 2G). Third, a monounsaturated fatty
acid, oleate (OA), failed to induce the dimerization of IRE1a-DLD
(Figures 2C and 2D), suggesting that the induced dimerization of
IRE1a-DLD in the palmitate-treated cells is specifically due to
lipid saturation. Furthermore, consistent with the previous study
(Volmer et al., 2013), tunicamycin, an ER stress inducer that per-
turbs protein folding in the ER lumen, was also unable to induce
the dimerization of IRE1a-DLD (Figures 2C and 2D). Therefore,
the enhanced dimerization of IRE1a-DLD in vivo is specific
to the increased lipid saturation due to palmitate.
To systematically identify the key residues responsible for the
dimerization of IRE1a-DLD, we performed alanine-scanning
mutagenesis on the IRE1a-TMD using the BiFC assay. All resi-
dues, except for two native alanines, were mutated to alanine
in the VN-IRE1a-DLD and VC-IRE1a-DLD constructs (Figure 2A).
Among the tested mutations, both S450A and W457A were not
able to reconstitute the fluorescence in the palmitate-treated
cells, indicating an inability to dimerize in the ERmembrane (Fig-
ures 2C and 2H). The loss of palmitate-induced dimerization of
IRE1a-DLD with the W457A and S450A mutants resulted in
a catalytically inactive state associated with their failure to
generate XBP1S (Figures 2F and 2G). The dimerization and
RNase defects of both W457A and S450A were not due to lower
levels of protein expression than the WT or mislocalization of the
mutant proteins under the palmitate-treated condition (Figures
2E, S2A, and S2B, respectively). The obtained Pearson’s corre-
lation coefficients for W457A and S450A were not significantly
different from the WT, suggesting that these mutants primarily
co-localize with the ER membrane marker protein calnexin in
the BSA- and palmitate-treated Hep3B cells (Figures S2A and
S2B). Therefore, our in vivo data demonstrate an essential role
of both Trp457 and Ser450 in modulating the palmitate-induced
dimerization of IRE1a-DLD.
IRE1a-TMD Serves as a Sensor for Lipid Membrane
Saturation in Mammals
Results of a previous study with the yeast Ire1 showed that the
juxtamembrane amphipathic helix, but not its TMD, plays aCell Reports 27, 307–320, April 2, 2019 309
Figure 2. W457A and S450A Mutations Abolish Both Dimerization and Activity of the IRE1a-DLD In Vivo
(A) Scheme of IRE1a-DLD constructs used in the BiFC assay. Myc-tagged Venus N terminus fragment and HA-tagged Venus C terminus fragment were inserted
between the signal peptide (SP) and the truncated LD. The amino acid residue numbers of the human IRE1a are shown in the boxes. The TMD sequence of IRE1a
is shown on top.
(B) Schematic diagram of the BiFC assay. Homodimerization of the IRE1a-DLD results in a functional Venus fluorescent protein.
(C) Specific homodimerization of IRE1a-DLD detected by BiFC. IRE1a/MEF cells co-expressing VN-IRE1a-DLD and VC-IRE1a-DLD or theirW457A and S450A
mutant constructs were treated with 2% BSA media, 0.4 mM palmitate (PA), or 0.4 mM oleate (OA) dissolved in 2% BSA media, or 5 mg/mL tunicamycin (Tm) for
2 h. The Venus fluorescence was detected by confocal microscopy. Scale bars, 42 mm.
(D) Fluorescence quantification for (C). The corrected total cell fluorescence (CTCF) was calculated for each cell and then normalized to the PA-treated samples.
Sixteen to 30 cells were quantified for each replicate. Values are reported as mean ± SD (n = 2); **p < 0.001 (Student’s t test).
(E) Western blot analysis of the total IRE1a-DLD expression levels. As described in (C), cells were treated with BSA or 0.4 mM PA for 2 h. GAPDH was used as a
loading control.
(F) RT-PCR of Xbp1 mRNA from cells transfected with VN-IRE1a-DLD and VC-IRE1a-DLD or their W457A and S450A mutant constructs. Cells were treated with
2% BSA or 0.4 mM PA for 2 h, and total mRNA isolated from the cells was subjected to RT-PCR analysis. The unspliced (U) and spliced (S) products and
heteroduplex species (HD) are indicated. GAPDH was used as a loading control.
(legend continued on next page)
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Figure 3. Mutations on the Juxtamembrane Amphipathic Helix Do Not Significantly Affect the Dimerization and Activity of IRE1a-DLD in the
Cells
(A) HeliQuest analysis of the amphipathic helix (IRE1a, 433–443 aa) (Gautier et al., 2008). Hydrophobic residues mutated to arginine (V437R and M440R) are
shown in blue, and the tryptophan residue is shown in red.
(B) IRE1a/ MEF cells co-expressing VN-IRE1a-DLD and VC-IRE1a-DLD or their V437R and M440R mutants were treated with 2% BSA or 0.4 mM PA for 2 h.
Venus fluorescence was detected with confocal microscopy. Scale bars, 42 mm.
(C) Quantification of Venus fluorescence in the presence of BSA or PA. The CTCF values were calculated for each treatment and mutation, and the fold changes
upon PA treatment were then normalized to the IRE1a-DLD-WT sample. Values are reported as mean ± SD (n = 2).
(D) Western blot analysis of the total IRE1a-DLD expression levels. GAPDH was used as a loading control.
(E) RT-PCR of Xbp1 mRNA from IRE1a/ MEF cells co-transfected with VC-IRE1a-DLD-WT and VN-IRE1a-DLD-WT or their mutants, V437R and M440R. BSA
and PA treatment conditions are the same as in (B).
(F) Quantification of splicing activity of IRE1a-DLD-WT, V437R, and M440R mutants in the presence of BSA or PA. Values are reported as mean ± SD (n = 3);
**p < 0.001 (Student’s t test).
See also Figure S2.crucial role in sensing aberrant physical membrane properties
(Halbleib et al., 2017). Because the amphipathic helix is
conserved on the human IRE1a (Figure 3A) (Halbleib et al.,
2017; Kono et al., 2017), we further assessed whether this is
also important in regulating the dimerization of IRE1a-DLD
through activation by membrane lipid saturation. To this end,
we mutated two conserved hydrophobic residues (V437 and
M440) on the amphipathic helix to arginine and performed the
BiFC assay. In contrast to the yeast Ire1 (Halbleib et al., 2017),
the two amphipathic helix mutations did not prevent the dimer-(G) Quantification of spliced XBP1 (XBP1S). The fraction of spliced Xbp1mRNA in
mean ± SD (n = 3); **p < 0.001 (Student’s t test).
(H) Alanine-scanning mutagenesis of the IRE1a-TMD. IRE1a/ MEF cells co-exp
PA for 2 h. The fold change of Venus fluorescence between the BSA- and PA-trea
SE (n = 2).
See also Figures S1 and S2.ization of the IRE1a-DLD in the ER membrane (Figures 3B and
3C). V437R andM440R helix mutant proteins had similar expres-
sion levels as the WT protein (Figure 3D), and they also co-local-
ized with calnexin in both the BSA and palmitate-treated cells
(Figures S2A and S2B). Furthermore, the amphipathic helix
mutant proteins exhibited wild-type (WT)-like XBP1 splicing ac-
tivity (Figures 3E and 3F). Therefore, together with the previous
study (Kono et al., 2017), our in vivo results strongly suggest
that the human IRE1a uses a different sensing mechanism for
membrane lipid saturation than the yeast Ire1.each sample was quantified as described in STARMethods. Data represent the
ressing alanine mutant VN and VC plasmids were treated with BSA or 0.4 mM
ted cells was quantified and normalized to WT. Values are reported as mean ±
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Figure 4. The Structural Elements in the IRE1a-TMD Sense Lipid Aberrancy and Activate the IRE1a-XBP1 Pathway
(A) Scheme of IRE1a full-length (FL) constructs used in the BiFC assay. The Myc-tagged Venus N terminus fragment and HA-tagged Venus C terminus fragment
were inserted between SP and LD.
(B) IRE1a/MEF cells co-expressing VN-IRE1a-WT-FL and VC-IRE1a-WT-FL, or their W457A and S450A mutants, were treated with 2% BSA or 0.4 mM PA for
2 h. Venus fluorescence was detected with confocal microscopy. Scale bars, 42 mm.
(C) Quantification of Venus fluorescence in (B). The CTCF values were calculated for each treatment and mutation. The fluorescence fold change upon PA
treatment was normalized to WT. Values are reported as mean ± SD (n = 3); **p < 0.001 (Student’s t test).
(D) Western blot of the WT and mutant samples with indicated antibodies. Total protein extracts were obtained from BSA- and PA-treated cells in (B).
(E) Quantification of the IRE1a foci-positive cells in (B). Percentage of cells that contain at least one IRE1a foci was calculated as described in STAR Methods.
Values are reported as mean ± SD (n = 3); *p < 0.05 (Student’s t test).
(F) RT-PCR of Xbp1 mRNA from IRE1a/MEF cells co-transfected with VC-IRE1a-FL-WT and VN-IRE1a-FL-WT or their mutantsW457A and S450A. Cells were
treated with 0.4 mM PA for 0, 0.5, 1, or 2 h. The unspliced (U) and spliced (S) products and heteroduplex species (HD) are indicated.
(G) Quantification of splicing activity of IRE1a-FL-WT, W457A, and S450A mutants in (E). Values are reported as mean ± SD (n = 2); **p < 0.001 (Student’s t test).
(H) RT-PCR of Xbp1 mRNA from IRE1a/ MEF cells transfected with pcDNA-hIRE1a-FL-Y161A, pcDNA-hIRE1a-FL-Y161A-W457A, and pcDNA-hIRE1a-FL-
Y161A-S450A. Cells were treated with BSA or 0.4 mM PA for 2 h.
(I) Quantification of splicing activity of IRE1a-FL-Y161A, IRE1a-FL-Y161A-W457A, and IRE1a-FL-Y161A-S450A. Values are mean ± SD, with n = 2; **p < 0.001
(Student’s t test). Error bars may not be visible because of low values.
See Figures S1 and S3.To exclude the possibility that the N-terminal LD affects the
dimerization conformation of the IRE1a-TMD, we used full-
length IRE1a BiFC constructs, VN-IRE1a-FL and VC-IRE1a-FL
(Figure 4A), and further monitored their dimerization in IRE1a/
MEF cells. Palmitate induced the dimerization of full-length312 Cell Reports 27, 307–320, April 2, 2019IRE1a, as evident by an increase in the reconstituted green fluo-
rescence (Figure 4B). Consistent with the observation of the
IRE1a-DLD (Figures 2C and 2H), both W457A and S450A muta-
tions on the IRE1a-FL dramatically reduced the dimerization in
the palmitate-treated cells (Figures 4B and 4C). Because the
Figure 5. Trp457 Residues Form an Aromatic Stacking Interaction in the Center of the TMD Dimerization Interface
(A) Left: Distance between the center of mass (CM) of the two indole rings of Trp457 in model B. Right: representative structures at various time points. The
colored indole rings correspond to the same colored arrows on the left.
(B) Left: Distance between the CM of Trp457 and Phe460 for each TMD peptide. Right: A representative structure of the aromatic pocket in the last 50 ns of the
simulation is shown.
(C) Left: Distance between two hydrogen atoms of the indole rings used to evaluate the alignment of the Trp457 in the simulation. Two hydrogen atoms at
positions 2 and 6 in the indole ring represent H1 (black) and H2 (red), respectively. Right: Average structure obtained from the last 50 ns of the simulation time. H1
and H2 are highlighted in black and red, respectively. Nitrogen atom is colored in blue, and other hydrogen atoms not considered for this analysis are colored in
white.
(legend continued on next page)
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active IRE1a dimers further facilitate the formation of high-order
oligomers that re-localize into discrete foci in vivo (Li et al., 2010),
we further calculated the IRE1a foci-positive cells. In agreement
with their dimerization capacity (Figures 4B and 4C), both the
W457A and S450A mutants significantly reduced the IRE1a
foci-positive cells (Figure 4D), while the total protein levels of
the IRE1amutants were unaltered (Figure 4E). In the BiFC exper-
iments, the fluorescence results only upon the formation of the
IRE1a dimer. Thus, the decreased number of foci-positive cells
in both mutants is due mainly to their reduced dimerization abil-
ity. In addition, because the expression levels of IRE1a-FL vari-
ants in the IRE1a/ MEF cells are similar to the endogenous
IRE1a level in the MEF-WT cells (Figures S1A, S1B, and 4E),
the dimerization and/or oligomerization defect in the W457A
and S450A mutants is unlikely due to non-physiologically high
concentrations of the IRE1a-FL variants. These full-length
IRE1a proteins co-localized with the ER membrane protein cal-
nexin, with similar Pearson’s correlation coefficients (Figures
S3A and S3B). Consistent with this, both the IRE1a-FL-W457A
and IRE1a-FL-S450A mutants in the palmitate-treated cells
showed significantly reduced XBP1S fractions (Figures 4F and
4G). Furthermore, tryptophan and serine residues in IRE1a-TMD
are highly conserved in mammals (Figure S3C). Therefore, these
results suggest that both Trp457 and Ser450 play a crucial role in
not only the initial dimerization process but also the IRE1a olig-
omer formation that could activate XBP1 splicing.
To further test whether the reduction of XBP1 splicing effi-
ciencies on the W457A and S450A mutants resulted from lipid
perturbation, but not accumulation of unfolded proteins upon
palmitate treatment, we used an established Y161A mutation
that is defective in sensing unfolded proteins (Kono et al.,
2017). Similar to the results with the IRE1a-DLD (Figures 2F
and 2G), the XBP1 splicing activities of both IRE1a-FL-Y161A-
W457A and IRE1a-FL-Y161A-S450A were significantly lower
than IRE1a-FL-Y161A (Figures 4Hand4I). Collectively, our in vivo
results suggest that the intrinsic structural elements of the
IRE1a-TMD could be a key factor in sensing membrane lipid
saturation in mammals.
MD Simulations Identified a Key Role of Trp457 in a
Potential Dimerization Process of the IRE1a-TMD
To further investigate the potential roles of both Trp457 and
Ser450 on the dimerization process of IRE1a-TMD, we per-
formed atomistic MD simulations, in which two IRE1a-TMD pep-(D) Residue contact numbers were calculated as the number of times each resid
simulation. The contact numbers were further normalized to the contact numbe
rescence) from the data in Figure 2H. Residues identified from both the MD simul
simulations, and residues identified only from the alanine-scanning experiments
(E) Location of residues identified from the MD simulations or alanine-scanning e
model B. Colors are shown as in (D).
(F) Density profile in z dimension of the Trp457 (red) and POPC head group (bl
distributions were collected from 10,000 snapshots during the last 50 ns of the
bilayer (< Zcf
2 > 1/2) was calculated over the last 50 ns of the simulation.
(G) Closer view of the density profile of (F).
(H) Nitroxide lipid quenching of IRE1a-TMD peptide in small unilamellar vesicles
quencher (5-doxyl PC) or deep quencher (16-doxyl PC) were prepared as describ
the emission spectra were obtained by scanning from 295 to 450 nm.
See also Figures S4–S6, Video S1, and Table S1.
314 Cell Reports 27, 307–320, April 2, 2019tides were inserted in an explicit POPC lipid bilayer. Because of
the lack of structural information on the IRE1a-TMD, three
different initial conformations of IRE1a-TMD were arbitrarily as-
signed (models A, B, and C) (Figure S4A). We estimated the
dimerization tendency of the TMD peptides in the POPC bilayer
on the basis of both the distance between the center of mass
(CM) of the peptides and the inter-peptide interactions. In model
A, the CM distance initially decreased from 11.8 A˚ (Figure S4B, X
mark) to 9.9 ± 0.4 A˚ and then returned to the initial value (Fig-
ure S4B). In model B, the CM distance decreased from 11.8 to
10.3 ± 0.3 A˚, while in model C, the CM distance increased to
14.0 A˚ (Figure S4B). Consistent with this, the total number of
atomic contacts within 6 A˚ between the two peptides in model
C was significantly lower than both models A and B (Figure S4C).
To analyze the nature of the inter-peptide interactions, we
calculated the average conformation of the three models over
the last 50 ns of the simulation. From the analysis, we found
that both models A and B have common conformational features
in the IRE1a-TMD peptides. First, the TMD peptides had a
slightly tilted conformation in the POPC bilayer, with tilt angles
of 8.9 ± 1.5 and 5.0 ± 2.0 in models A andB, respectively (Fig-
ure S4D). In contrast, to escape from the hydrophobic acyl
chains of the POPC to the more polar head groups, the hydro-
philic TMD residues in model C rearranged drastically, thereby
leading to a deformed and tilted conformation in the membrane
(Figure S4D) (Killian, 1998). Second, Trp457 was observed in the
dimerization interface of the TMDpeptides. In the simulation with
model A, Trp457 in TMD1 and Trp457 and Phe460 in TMD2 were
clustered at the interface of the TMD peptides (Figure S5A). In
this interface, Trp457 in TMD1 and Phe460 in TMD2 formed
the T-shaped aromatic interaction, which is slightly greater
(6 A˚) than an ideal T-shaped stacking value (5 A˚) (Janowski
and Pulay, 2007) (Figure S5B). In the initial structure of model
B, the two Trp457 residues were located on the opposite sides
of the TMD peptides (CM distance = 14 A˚; Figure 5A, green).
However, they rapidly changed orientations to relocate to the
center of the TMD peptide interface, forming a stable aromatic
interaction (CM distance = 4–5 A˚; Figure 5A, orange) (also see
Video S1). Similar to model A (Figure S5A), the position of
Trp457 at the interface was transiently stabilized by the aromatic
interactions with the Phe460 residue during the simulation (Fig-
ure 5B). Given that F460A did not exhibit any significant defect
in the dimerization of IRE1a-DLD in vivo (Figure 2H), the
observed Phe460-Trp457 interactions in models A and B couldue comes within 6 A˚ of the dimerization interface during the last 50 ns of the
r of the Trp457 residue. Dimerization deficiency was calculated as (1  fluo-
ations and alanine-scanning experiments, residues identified only from the MD
are shown in red, blue, and green, respectively.
xperiments are highlighted on the IRE1a-TMD dimer structure obtained from
ack) as a function of distance from the center of the membrane. The density
simulations. The root-mean-square distance of Trp457 from the center of the
(SUVs). The SUVs containing TMD peptide, POPC, and spin-labeled shallow
ed in STARMethods. The tryptophan fluorescence was excited at 280 nm, and
be intermediate states that are not essential for the IRE1a-TMD
dimerization. After the first 150 ns of simulation of model B, the
distance between the benzene and indole centroids decreased
(Figure 5C, left), creating an aromatic pocket with an ideal aro-
matic sandwich stacking configuration of the tryptophan resi-
dues (Figure 5C, right). Furthermore, the ring orientations of
Trp457 allowed the formation of H-bonds between the NH of
the indole groups and the carbonyl oxygen of Trp457, Leu454,
and Leu453 (Figures S6A and S6B). In addition to Trp457,
Ser450, located near the N terminus of the TMD, transiently
formed H-bonds with Ser450 and Thr446 on the other peptide
(Figures S6C and S6D). Interestingly, inspection of the average
conformation of model C revealed that the Trp457 was not
located at the interface, suggesting that the lack of the Trp457
at the peptide interface could destabilize the dimer of
IRE1a-TMD, inducing a dramatically tilted conformation in the
POPC bilayer (Figure S4D). Together with the in vivo experi-
mental results (Figures 2 and 4), the MD simulation results from
both models A and B suggest that Trp457 could play a key role
in the IRE1a-TMD dimerization process.
To provide broad insight on the alanine mutagenesis results
(Figure 2H), we further calculated the atomic contact number
(cutoff = 6 A˚) for each residue in model B. The analysis revealed
that Trp457 was the most frequently localized residue to the
dimerization interface during the last 50 ns of simulation time
(normalized to 1 in Figure 5D), and residues including Thr446,
Ser450, Leu453, and Leu454 had about 30%–40% of the con-
tact numbers of Trp457 (Figure 5D). This is consistent with the
in vivo data showing that W457A, S450A, and T446A have de-
fects in the dimerization of IRE1a-DLD (Figure 5D, red). By
contrast, the alanine mutation of both Leu453 and Leu454 did
not alter the dimerization efficiency of IRE1a-DLD (Figure 5D,
blue). In addition, both the I447A and I461A mutants exhibited
less than 50% of the WT dimerization efficiency (Figure 5D,
green). It is notable that all the defective residues identified
from the BiFC assay (Figure 2H) are localized in the dimerization
interface obtained frommodel B (Figure 5E). Therefore, we spec-
ulate that model B could represent the initial dimerization stages
of the IRE1a-TMD.
Trp457 Locates Near the Center of the POPC Bilayer
Tryptophan is found abundantly in membrane proteins. Because
of its amphipathic nature, tryptophan is known to stabilize the
membrane proteins by anchoring the interactions in the mem-
brane-water interface (Yau et al., 1998). However, tryptophan
often locates toward the center of the TMD helix to support the
aromatic interaction, which mediates the TMD dimerization
(Haeger et al., 2010; Ridder et al., 2005; Sal-Man et al., 2007).
Our bioinformatics analysis revealed that about 30% of the
single-spanning transmembrane proteins (a total of 2,365
human proteins) contain tryptophan residues. One-fifth of these
proteins have tryptophan near the center of the lipid bilayer (cut-
off = ±30% from the center amino acid residue in the TMdomain)
(Table S1). Using the MD simulation results, we further analyzed
both the density profile of the Trp457 and POPC head group as a
function of the distance from the bilayer center along the direc-
tion normal to the bilayer plane (Figure 5F). The preferred loca-
tion of Trp457 is close to the center of the lipid bilayer (i.e., thehydrophobic core region of the POPC bilayer; Figures 5F and
5G). The calculated root-mean-square distance of Trp457 from
the center of the bilayer (<Zcf
2 > 1/2) is 0.76 ± 0.12 A˚, corrobo-
rating a density profile that locates the tryptophan residues in
proximity of the center of the POPC lipid bilayer.
To experimentally determine the location of Trp457 in the
POPC lipid bilayer, we used the parallax method that estimates
the membrane penetration depth of the tryptophan residue
(Chattopadhyay and London, 1987). The parallax method allows
the determination of the apparent location of tryptophan by
comparing the quenching of the tryptophan fluorescence by
two different spin-labeled POPC lipids, 5-doxyl PC (shallower
quencher), and 16-doxyl PC (deeper quencher). Compared with
the fluorescence intensity in the absence of the quenchers (Fig-
ure 5H, black), Trp457 was quenched dramatically by the deeply
located nitroxide lipid quencher (F/F0 = 0.099) (Figure 5H, red),
but much less efficiently by the shallow quencher (F/F0 = 0.71)
(Figure 5H, blue). We further calculated the distance of Trp457
from the center of the bilayer (Zcf), as described in STAR
Methods. The average depth of penetration of Trp457 from the
center of the bilayer was estimated at 0.88 ± 0.35 A˚, consistent
with the computationally calculated value of 0.76± 0.12 A˚. There-
fore, both the computational and experimental results indicate
that the tryptophan residue locates near the center of the bilayer.
Intrinsic Structural Features of Trp457Are Important for
the Dimerization Process of IRE1a-TMD
Of the aromatic residues, the side chain of tryptophan is unique
with its amphipathic nature, enabling it to participate in both ar-
omatic interactions and hydrogen bonding (NH-p and CH-p)
(Samanta et al., 1999). This multi-functional side chain makes
the tryptophan residue a key contributor to both the process of
protein folding and stabilization of the folded protein structures.
To address whether the tryptophan residue is a unique feature in
the 457 position for the IRE1a-TMD dimerization, Trp457 was
mutated to either alanine or phenylalanine. W457F preserves
the aromatic ring but removes both the H-bond donor and dipole
moment properties of the tryptophan, whereas W457A removes
both the aromatic interactions and hydrogen bonds. Both
W457A and W457F mutants significantly reduced the dimeriza-
tion ability of IRE1a-TMD in the cellular membrane (Figure 6A).
Therefore, the experimental results suggest that the aromatic
characteristic alone is insufficient to promote self-association,
and the H-bond or the dipole moment on the tryptophan residue
could be important in regulating the TMD dimerization of the
IRE1a protein.
To elucidate the potential role of tryptophan on the TMD
dimerization process, we performed further MD simulations of
the W457 mutants (W457A and W457F) (Figures 6B and 6C)
starting from the initial conformation of model B. The CM dis-
tances of W457A and W457F were not significantly different
from the WT (Figure 6D). In the W457F model, in contrast to
the WT (Figure 5A), the benzene ring only formed a T-shaped ar-
omatic interaction during the first half of the simulation (CM dis-
tance = 6 A˚; Figure 6E, blue), and then they moved apart,
breaking the aromatic interaction in the last 100 ns (CM dis-
tance = 7.3 A˚; Figure 6E, red and orange). Therefore, both the
computational and experimental results suggest that theCell Reports 27, 307–320, April 2, 2019 315
Figure 6. Intrinsic Structural Features of Trp457 Are Important for the Dimerization Process of IRE1a-TMD, and Ser450 Stabilizes the Trp457-
Trp457 Interaction
(A) TOXCAT assays of IRE1a-TMD-WT and its W457A and W457F mutants. Top: CAT activities from cells expressing ToxR-TMD-MBP were quantified and
normalized to the WT. Bottom: the protein expression levels for each sample were also normalized to the ToxR-TMD-MBP protein. Values are mean ± SD (n = 6);
**p < 0.001 (Student’s t test).
(B) Initial (0 ns) and final (200 ns) conformation of the W457A mutant. The mutated alanine residues are colored in red.
(C) Initial and final conformations of the W457F mutant. The mutated phenylalanine residues are colored in red.
(D) Distance between the CM of the TMD peptides. The black, orange, and blue lines correspond to the WT, W457A, and W457F mutants, respectively.
(E) Left: distance betweenW457F residues asmeasured from the CM of the two benzene rings. Right: representative structures at various time points. The colors
of the phenylalanine residues match the color of the arrows on the left.
(F) Initial and final conformations of the S450A mutant. Both mutated serine residues and Trp457 residues are colored in red and magenta, respectively.
(G) Distance between the CM of WT (black) and S450A (red) peptides.
(H) Distance between the indole rings of Trp457 residues in WT (black) and S450A (red) peptides.
See also Figure S7.predominant effect of the W/F substitution results from the
removal of the electrostatic interactions between the indole
dipole and the polar groups, supporting that the aromatic char-
acteristic alone is insufficient to drive the TMD dimerization.316 Cell Reports 27, 307–320, April 2, 2019To further understand the potential mechanisms by which
Ser450 regulates the dimerization of IRE1a-TMD, we performed
MD simulations with the S450A peptides (Figure 6F). Serine sub-
stitution to alanine only changes the side chain of CH2OH to CH3,
Figure 7. The Proposed Model of IRE1a Activation by Membrane Lipid Saturation
Under normal conditions, IRE1a presents as an inactive monomer. Upon palmitate treatment, the center-localized tryptophan residues (red) rapidly initiate the
TMD dimerization process and support the core interactions for the IRE1a-TMD. The serine residue (green) assists in the stability of the TMD dimer during this
process. The dimerization of IRE1a-TMD further induces dimerization of LD, KD, and RD, subsequently resulting in an active conformation.thus eliminating the capability of H-bonds. The CM distance be-
tween the S450A peptides increased significantly compared
with WT (Figure 6G). As observed in the WT (Figure 5A), the
CM distance between the indole rings on Trp457 also rapidly
decreased (14–7.5 A˚) in S450A. Because of the loss of H-bonds,
this distance increased back to 9.5 A˚ and remained constant
over the simulation time, except for a short period around
100 ns (Figure 6H). Therefore, the MD simulation results suggest
that the primary effect of S450A could be a loss of the Trp457-
Trp457 interactions. If this hypothesis is correct, we would not
observe any synergetic effect in the S450A-W457A double-
mutant cells. Consistent with this notion, the dimerization effi-
ciency of IRE1a in the S450A-W457A cells is approximately
20% of theWT and thus is not significantly different from the sin-
gle mutant (S450A or W457A) cells (Figures S7A and S7B versus
4B and 4C). Taken together, the H-bonds formed by Ser450
could contribute to the stability of the Trp457-Trp457 interaction
during the IRE1a-TMD dimerization process.
DISCUSSION
Here we propose a mechanistic model of human IRE1a activa-
tion by membrane lipid saturation. Under normal conditions,
four functional domains (LD, TMD, KD, and RD) of the IRE1a pre-
sent in an inactive monomer conformation (Figure 7). In partic-
ular, the Trp457 residue could remain on the opposite side of
the dimerization interface (Figure 7, back to back). Given that
palmitate alters the physical properties of the membrane (e.g.,
fluidity and lipid packing; Covino et al., 2016; Leekumjorn
et al., 2008), the tryptophan residues rapidly rotate and support
the core dimerization interface of the IRE1a-TMD (Figure 7, face
to face). In addition, the Ser450 residue assists the dimerization
stability, potentially because of its capacity for H-bonds. The
dimerization of the IRE1a-TMD further brings the cytosolic
domains together, which could induce the face-to-face confor-
mation of KD by a currently unknown mechanism, leading sub-
sequently to an active, phosphorylated conformation (Figure 7)
(Ali et al., 2011; Li et al., 2010). The activated IRE1a enables
the cleavage of the Xbp1 mRNA for downstream transcriptional
regulation of UPR genes. Therefore, our results showed that theTMD of IRE1a serves as an active signaling modulator of mem-
brane lipid saturation.
Several previous studies suggest that tryptophan supports
self-association of the helical TMD segments (Haeger et al.,
2010; Ridder et al., 2005; Sal-Man et al., 2007). Our study further
demonstrates that the conserved tryptophan (Figure S3C) is an
essential amino acid residue for the dimerization process. In
addition, the chloride intracellular channel protein 1 (CLIC1),
one of the positive hits in our tryptophan location analysis (Table
S1), has been shown previously to stabilize the TM dimerization
in the membrane by the cation (Lys37)-p interaction (Trp35)
(Peter et al., 2014). The WxK motif is known to increase the
strength of oligomerization of the TMD helices (Johnson et al.,
2007), and it is conserved on the chloride intracellular channel
protein family except for CLIC3 (Table S1). Remarkably, the tryp-
tophan location analysis showed that another ER sensor protein,
PERK, has two conserved tryptophan residues (Trp521 and
Trp522) near the center of the TMD sequence (Table S1), sug-
gesting that dimerization of the PERK TMdomainmight bemedi-
ated by the cation (Lys523)-p interaction (Trp521). Nevertheless,
whether the tryptophan residues play a crucial role in activating
the PERK protein remains to be tested.
An intriguing feature we observed in the MD simulations is a
rotameric switch of the tryptophan residue of IRE1a-TMD (Fig-
ure 5A; Video S1). In model B, two Trp457 residues initially
pointed in opposite directions, and then they rapidly flipped to-
ward the center of the TM dimerization interface to maximize
their interactions (Figure 5A; Video S1). The rotameric switch
could optimize the IRE1a-TMD interface by providing the driving
force for other H-bonds to form (Figures S6A and S6B). The tryp-
tophan rotameric switch model is most commonly observed in G
protein-coupled receptors (GPCRs). A highly conserved trypto-
phan residue (Trp6.48) in TMD6 was rotated toward another
conserved phenylalanine residue (Phe5.47) in TMD5, and these
two aromatic residues formed an edge-to-face aromatic interac-
tion (Holst et al., 2010; Li et al., 2013; Lyman et al., 2009). This
rotameric switch is known to be involved in the activation pro-
cess of GPCRs (Holst et al., 2010; Li et al., 2013; Schwartz
et al., 2006). Interestingly, a recent study showed that Trp1042
on the TMdomain of theMga2 protein senses the lipid saturationCell Reports 27, 307–320, April 2, 2019 317
of the yeast ERmembrane and subsequently triggers the TM he-
lix rotation to induce an active Mga2 conformation for transcrip-
tional upregulation of fatty acid desaturation (Covino et al., 2016).
Consistent with this, our MD simulation and in vivo results sug-
gest that the Trp457 rotameric switch of the IRE1a-TMD induced
by palmitate triggers the active conformation of the cytosolic
domain of the IRE1a protein to induce XBP1 mRNA splicing.
Taken together, the rotameric switch could be important for acti-
vation of membrane proteins.
In addition to the tryptophan residue, the MD simulations pre-
dicted that the residues at the interface of the IRE1a-TM domain
consisting of Ser450, Leu453, and Leu454 are involved in the
H-bonds and hydrophobic interactions (Figures 5D, S6C, and
S6D). Our BiFC experiments showed that S450A dramatically re-
duces thedimerizationof the IRE1a (Figures2and4). Interestingly,
these residues are located as a leucine-zipper-likemotif (SxxLxxx
motif) (Figure S3C), which was also observed in the parallel TM
dimerization of the mouse erythropoietin receptor (EpoR) protein
(Ruan et al., 2004). In addition, both the tryptophan and SxxLxxx
motif on IRE1a are highly conserved in mammals but not in yeast
Ire1 (Figure S3C) (Kono et al., 2017). Because of the different ER
membrane lipid composition between yeast and mammals (van
Meer et al., 2008), the TMD sequences on the IRE1a protein of
mammals could have evolved to be particularly sensitive to lipids
in the ER membrane, while the yeast Ire1 relies on the juxtamem-
brane amphipathic helix sequences (Halbleib et al., 2017).
Why are the intrinsic structural features of the IRE1a-TMD
required for sensing the membrane lipid perturbation? The re-
sults of a previous study showed that replacing the IRE1a-TMD
sequence by its scrambled TMD sequence or calnexin TMD
sequence did not completely abolish the XBP1 splicing activity
of the IRE1a protein (Volmer et al., 2013). However, the XBP1
splicing efficiencies for those two constructs and the WT under
the same treatment conditions were significantly different in
the IRE1a-FL and IRE1a-DLD expressing cells (Volmer et al.,
2013), suggesting that the IRE1a-TMD sequence cannot be fully
replaced. Given that the UPR signaling pathways are dynami-
cally modulated by palmitate (Cho et al., 2013), the intrinsic
structural feature of the IRE1a-TMD could be crucial for fine-tun-
ing the dynamic UPR signaling induced by membrane lipid
saturation. The bulky tryptophan residue 457 could be accom-
modated in the loosely packed lipid bilayer, whereas in a more
densely packed bilayer, the formation of Trp457-Trp457 aro-
matic stacking interaction would be energetically more favorable
(Covino et al., 2016). On the basis of our MD simulation results,
this rotation is expected to be very fast (10 ns) (Figure 5A)
and thus would allow rapid response to small lipid perturbations
in the ER membrane. In contrast, because of lipid packing in the
presence of palmitate, the TMD lacking the tryptophan residue
could passively diffuse and eventually dimerize under prolonged
palmitate exposure (Kono et al., 2017). Although this hypothesis
remains to be tested, we propose that the tryptophan residue in
the IRE1a-TMD enables a dynamic switch by rapid rotation upon
membrane lipid saturation.
From theMD simulation results, we propose that the dimeriza-
tion process of IRE1a-TMD uses a ‘‘dual-lock’’ strategy. In this
scenario, the Trp457 is a core lock that buttresses the dimeriza-
tion interface, and the Ser450 is a secondary lock that further se-318 Cell Reports 27, 307–320, April 2, 2019cures the core interactions. The S450A mutant showed a partial
rotation of Trp457 residues (Figures 6F and 6H), representing an
intermediate state during the IRE1a-TMD dimerization process.
This intermediate state would sense the perturbation of the lipid
composition in the ER membrane, however, it is insufficient to
drive a stable dimerization of the IRE1a-TMD and to transmit sig-
nals to the cytosolic domain of IRE1a in vivo (Figures 2 and 4).
Further mechanistic study is needed to confirm that S450A is
an isolated mutant that decouples lipid saturation sensing from
the dimerization of IRE1a-TMD; nonetheless, we suggest that
the full rotation of the Trp457 residues is required for an active
conformation of IRE1a.
Whereas the conventional UPR initiates by BiP release from
IRE1a-LD upon accumulation of unfolded proteins in the ER
lumen and subsequent dimerization of IRE1a-LD, our data with
IRE1a-DLD and IRE1a-Y161A (Figures 2 and 4) demonstrate
that palmitate directly activates IRE1a through the dimerization
of the TMD. This further suggests that, depending on the nature
of the physiological stimuli, IRE1a could use different sensing
mechanisms. Given that IRE1a dynamically assembles with
numerous co-factors and regulators to activate its cytosolic
domain that constitutes the UPRosome (Hetz and Glimcher,
2009), whether this non-canonical activation of IRE1a by lipid
perturbation requires specific factors in the UPRosome is
currently unknown. Interestingly, a recent study showed that
Bax/Bak, one of the co-factors that binds to the cytosolic domain
of IRE1a (Hetz et al., 2006), is required for palmitate-induced
activation of ER stress (Zhang et al., 2019). Therefore, the map-
ping of the IRE1aUPRosome that is induced by lipid perturbation
remains to be explored. This, together with our results, would
provide further insight into how IRE1a could customize its
sensing and regulatory domains for a specific stimulus.STAR+METHODS
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EXPERIMENTAL MODEL AND SUBJECT DETAILS
Cell lines used
IRE1a/ Mouse Embryonic Fibroblast (MEF) cells (embryos were of unknown sex at the time that the cells were obtained), were
grown in DMEMcontaining 4500mg/L glucose, L-glutamine, sodium pyruvate and sodium bicarbonate supplementedwith 10% fetal
bovine serum +10% FBS at 37C in 5% CO2
Hep3B (8 year old male) grown in DMEM containing 4500 mg/L glucose, L-glutamine, sodium pyruvate and sodium bicarbonate
supplemented with 10% fetal bovine serum +10% FBS at 37C in 5% CO2
METHOD DETAILS
Cell culture and transfection
IRE1a–/– mouse embryonic fibroblast (MEF) cells were maintained at 37C at 5%CO2 in Dulbecco’s Modified Eagle Medium (DMEM,
Thermo cat# 11995065) containing 4500 mg/L glucose, L-glutamine, sodium pyruvate, and sodium bicarbonate supplemented with
10% fetal bovine serum. Cells were reverse-transfected with Lipofectamine LTX reagent (Thermo Fisher Scientific) for 24 h. After-
ward, the media was removed and replaced with complete media containing only 2% bovine serum albumin (BSA) or 0.4 mM palmi-
tate (PA) in 2% BSA media.
Cloning of VC-IRE1a and VN-IRE1a plasmids
pBiFC-VC155 and pBiFC-VN155 (I152L) were a gift from Chang-Deng Hu (Addgene plasmid # 22011 and #27097) (Shyu et al., 2006).
pcDNA-hIRE1a (a gift originally from Randal J. Kaufman (University of Michigan, MI, USA)) was used to amplify the IRE1a gene. Ane2 Cell Reports 27, 307–320.e1–e5, April 2, 2019
IRE1a signal peptide sequence (1-18 aa) was added at the N-terminal of the coding sequence upstream of the HA- and Myc-tagged
VC and VN fragments. The coding sequences of the truncated luminal domain (19-29aa, 408-443aa) followed by the transmembrane
and cytosolic domains (444-977 aa) were inserted at the C terminus of the VC and VN fragments (see Figure 2A). For the IRE1a-full
length BiFC constructs, the HA- and Myc-tagged VC and VN fragments were inserted between the signal peptide sequence and the
C terminus coding sequences of IRE1a (18-977aa). Primers for the alanine point mutations of IRE1a-TMD and the V437R, M440R,
Y161A mutations were designed and performed according to guidelines from the QuikChange Lightning Site-Directed Mutagenesis
kit (Agilent). The sequences of the mutations were confirmed by DNA sequencing services (Eurofins Genomics).
Immunofluorescence
Hep3B Cells were reverse-transfected with pBiFC-VC155-IRE1a-DLD and pBiFC-VN155-IRE1a-DLD or pBiFC-VC155-IRE1a-FL
and pBiFC-VN155-IRE1a-FL plasmids using Lipofectamine LTX for 24 h and then fixed, permeabilized, and co-stained with an
anti-calnexin antibody (Santa Cruz Biotech, cat# sc-23954), an anti-HA antibody (Abcam, cat# ab9110), or an anti-Myc antibody (Ab-
cam, cat# ab9106). Appropriate secondary antibodies conjugated with Alexa 488 (Abcam, cat# 150077) or Alexa 568 (Abcam cat#
175701) were further incubated. Representative images for cells expressing Myc-VN-IRE1a-DLD protein are shown although the
cells expressing HA-VC- IRE1a-DLD protein had the same colocalization pattern.
Bimolecular fluorescence complementation (BiFC) assay
m-plates (Ibidi) were used for confocal microscopy to detect Venus fluorescence. IRE1a–/– MEF cells were seeded at a density of
3 3 106 cells/mL in each well and co-transfected with VN155-IRE1a-DLD and VC155-IRE1a-DLD (WT or V437R/M440R/W457A/
S450A) plasmids. Cells were transfected as described above and then treated with BSA or PA media for 2 h. The Olympus FluoView
FV1000 imaging system, with an UPLFLN 20X NA 0.5 objective and a PLAPON 60X O NA 1.42 objective, was used to observe the
formation of the Venus fluorophore at lex = 515nm and lem = 535nm. The BiFC assay for IRE1a-FL was performed for the same
conditions as IRE1a-DLD constructs using the VN155-IRE1a-FL and VC155-IRE1a-FL (WT or W457A/S450A/W457A-S450A) plas-
mids. The corrected total cell fluorescence (CTCF) was calculated for each cell (McCloy et al., 2014) using the following equation:
CTCF = [Integrated Density – (Area of selected cell3mean fluorescence of background readings)]. The number of cells that contain
at least one foci was analyzed using ImageJ (Fiji) software with the following parameter settings, threshold 15-255, circularity 0-1, and
size (pixel2) 100-10000.
XBP1 splicing assay
IRE1a–/– MEF cells were reverse-transfected with the plasmids as described above. Total mRNAwas collected and the one-step RT-
PCR kit (QIAGEN) was used to amplify XBP1 cDNA. PCR primers were designed to flank the 26-bp splicing sequence of XBP1. PCR
reaction was performed using the following primers: mXBP1-f 50–GAACCAGGAGTTAAGAACACG–30 and mXBP1-r 50–AGGCAA
CAGTGTCAGAGTCC–30. The PCR products were run on a 2.5% agarose gel made in 0.5X TBE. Gels were visualized and quantified
usingMolecular Imager ChemiDoc XRSSystem (Bio Rad). The splicing efficiency of XBP1 (%XBP1) was calculatedwith the following
equation: XBP1 splicing (%) = [Intensity (XBP1S) + 0.5*Intensity (XBP1HD)] / [Intensity (XBP1S) + Intensity (XBP1HD) + Intensity
(XBP1U)]*100
Fo¨rster resonance energy transfer (FRET) measurements
The lysine residues on the N and C-termini (K-444KDMATIILSTFLLIGWVAFIITYPLS467-KK) were added to enhance the solubility and
stability in the lipid bilayer. Unlabeled TM peptide and N-terminal labeled-TMD peptides with FITC (Fluorescein isothiocyanate) or
Carboxytetramethylrhodamine (TAMRA) were synthesized from Peptide 2.0 Inc. Peptides dissolved in TFE (Trifluoroethanol) and
POPC (1-palmitoyl 2-oleoyl phosphatidylcholine) suspended in chloroform were mixed and then the organic solvents were removed
using a nitrogen gas stream. The peptide/lipid mixture was reconstituted in 10 mM phosphate buffer (pH 7.0) containing 500 mM
NaCl, freeze-thawed three times, and equilibrated at RT for 1 h before the fluorescence measurement.
FRET experiments were performed with FluoroMax-4 (Horiba), as previously described (Cho et al., 2012). For FITC and TAMRA as
a donor/acceptor pair, the excitation wavelength was set at 439 nm and emission spectra were collected from 480 to 650 nm. FRET
efficiency was calculated from measurements of donor fluorescence intensity at 515 nm in the absence and presence of the
acceptor: FRET efficiency = (ID  IDA)/(ID), where ID and IDA are the donor fluorescence intensities of the samples containing
only donor-labeled peptides and the samples with both donor- and acceptor-labeled peptides, respectively. The contribution to
the emission at 515 nm from the direct excitation of the acceptor was removed by subtracting the spectra of the samples containing
only acceptor-labeled peptides. In addition, the background signal from the lipid was eliminated by subtracting the spectra of lipo-
some samples without peptides.
SDS-PAGE for IRE1a-TMD peptide
The IRE1a-TMD at the final concentration 2 mM was incubated in 1X lithium dodecyl sulfate (LDS) buffer (final concentration = 2%
LDS) (ThermoFisher Scientific Inc., cat# NP0007) for 20 min at room temperature. 5 mL of sample was loaded onto 9% Bis-Tris
gel and ran in MES buffer. Spectra Multicolor Low Range Protein Ladder (Thermo Fisher Scientific Inc., cat# 26628) was used as
a molecular weight marker. The IRE1a-TMD peptides were visualized with Silver staining.Cell Reports 27, 307–320.e1–e5, April 2, 2019 e3
Tryptophan fluorescence measurements and tryptophan depth calculation
For nitroxide lipid quenching experiments, the small unilamellar vesicles (SUVs) were prepared by amodifiedmethod from a previous
study (Maiorano and Davidson, 2000). The spin labels used, 5 doxyl PC (1-palmitoyl-2-stearoyl-(5-doxyl)-sn-glycero-3-phosphocho-
line) and 16 doxyl PC (1-palmitoyl-2-stearoyl-(16-doxyl)-sn-glycero-3-phosphocholine) were obtained from Avanti Lipids. The molar
ratio of POPC: doxylPC: peptide was 68:12:1 for all the assays. The lipid and peptide mixture in chloroform was dried under nitrogen,
vacuum dessicated for 8 h to remove all traces of chloroform. 10 mL ethanol was further added to the lipid-peptide film. The sample
was then vortexed and incubated on ice for 10 min. After diluting the sample with 1 mL of 10 mM Tris-HCl buffer (pH 7.0), bath son-
ication was performed for 1 h. The spectra were recorded at room temperature on a Fluoromax-4 at lex = 280nm. Emission spectra
were collected from295nm to 450nm. The fluorescence fromPOPCSUVswas subtracted from the samples containing spin label and
peptide.
The distance of the Trp from the center of the bilayer (Zcf) is calculated with the following equation (Ren et al., 1997):
Zcf = Lcd 
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where F0 is the fluorescence intensity in the absence of quencher, Fs is the fluorescence intensity in the presence of the shallow
quencher (5-doxyl PC), Fd is the fluorescence intensity in the presence of the deep quencher (16-doxyl PC), Lcd is the distance
from the center of the bilayer to the deep quencher (2.25 A˚), and Lds is the distance between the shallow (12.15 A˚) and deep
quenchers.
TOXCAT chimera constructions and assay
The TOXCAT vectors, pccKAN (TM deficient negative control), pccGpA-WT (positive control), and pccGpA-G83I (negative control),
along with NT326 (malE deficient) E.coli strain, were kindly provided by Dr. DonaldM. Engelman (Yale University, CT, USA) (Russ and
Engelman, 1999). DNA fragment coding for the IRE1a-TMD residues (444-466 aa) was amplified from the plasmid pcDNA-hIRE1a
and then inserted in-frame into the NheI and BamHI sites of pccKAN to generate the ToxR-IRE1a-TMD-MBP (maltose binding pro-
tein) fusion protein. Individual mutants of IRE1a-TMD were created through mutation of the pcc-IRE1a-WT plasmid using the
QuikChange Lightning site-directed mutagenesis kit (Agilent). The TOXCAT chimeras were transformed into NT326 cells and grown
at 37C until A600 was 0.6. The harvested cells were lysed using the xTractor cell lysis buffer (Clontech) containing 0.2 mg/mL
lysozyme. The CAT concentration was quantified with the CAT enzyme-linked immunosorbent assay kit (Roche Applied Science)
according to the product manual. Chimera protein expression was quantified with western blotting using anti-MBP antibody (New
England Biolabs, cat# E8032) and used to normalize the CAT activity of the various constructs.
MalE complementation assay
To confirm correct membrane insertion, NT326 cells expressing the TOXCAT chimeras were grown overnight in LB media. The cells
were inoculated in M9 minimal media and cultured for 8 h. The cells were streaked onto M9 minimal media agar plates containing
0.4% maltose as the only carbon source and incubated for 3 days at 37C. The images of the agar plates were collected using
the Molecular Imager ChemiDoc XRS System (Bio Rad).
Molecular dynamics (MD) protocol
MD simulations of the TM peptides in lipid bilayer were performed with the GROningen MAchine for Chemical Simulations
(GROMACS) v4.5.4 package (Hess et al., 2008), using the gromos53a6 force field, extended to improve the simulation of the lipid
components consistent with our previous work (Leekumjorn and Sum, 2007; Leekumjorn et al., 2008; Marrink et al., 1998; Sirk
et al., 2008). The lipid bilayer consisted of 288 1-palmitoyl 2-oleoyl phosphatidylcholine (POPC) lipids and 11500 water moleculese4 Cell Reports 27, 307–320.e1–e5, April 2, 2019
(SPC model) in the liquid–crystalline state (gel-to-liquid crystalline phase transition at 270 K (Litman et al., 1991)). This model was
chosen since it gives an approximate representation of the phospholipid constituents in the ER (Buchan et al., 2010).
The topology file for the POPCmolecule was consistent with the previous topology described in (Leekumjorn and Sum, 2007; Lee-
kumjorn et al., 2008; Marrink et al., 1998; Sirk et al., 2008). An initial 100 ns MD simulation of a pure POPC bilayer was performed to
equilibrate the membrane. The TM helix sequence and all mutants were built with the PyMol software (De Lano, 2002), assigning an
a-helical conformation as predicted by PSIPRED: Protein Structure Prediction Server (http://bioinf.cs.ucl.ac.uk/psipred_new/) (Bu-
chan et al., 2013). We built three different dimer models of the TM peptides (models A, B, C). Starting from a dimer conformation
(model A), the other two potential dimers were gained by systematically rotating each TMpeptide 90 in model A around its backbone
(z axis) clockwise or counter-clockwise (Zhang et al., 2012). All the TM chains in the three dimer models have the same initial confor-
mation and the only difference for the three dimers is the helix-helix interface.
The TM segments were then inserted in the pre-equilibrated POPC bilayer at 1.2 nm from each other. The insertion required
the removal of two lipid molecules per leaflet. Chloride ions were added to neutralize the charges in the simulation box. To relax
the bond geometries, the potential energy of the system (lipid bilayer, peptides, water and ions) was minimized by using the steep-
est-descent method until convergence was reached. The solvent was then relaxed by 1 ns of MD at 300K, restraining the peptides’
atomic positions with a harmonic potential of 1000 kJ mol1 nm2 and then for another 1 ns decreasing the harmonic potential to
500 kJ mol1 nm2. The production simulations were performed at 300 K and 1 bar in an isothermal-isobaric ensemble (NPT), using
the Berendsen thermostat and barostat. Lipids, water, peptide, and counterions were separately coupled to the temperature bath by
weak coupling with a coupling constant of 0.1 ps. The pressure was also weakly coupled (with a coupling constant of 1.0 ps and
compressibility of 4.5 3 105 using a semi-isotropic scheme in which only the pressure in the x and y were coupled together, but
the normal pressure (in the z-direction) was not, as recommended for membrane protein simulations.
A simulation time step of 2 fs was used with all bond lengths constrained via the LINCS algorithm. Long-range electrostatic inter-
actions were calculated with the Particle-Mesh Ewald (PME) method. Short-range interactions were cut-off at 1 nm. The production
run consisted of 200 ns, and only the last 50 ns were used for the calculation of the average structure. The configurations in these
production runs were stored every 2500 steps (5 ps), ensuring negligible statistical correlation between successively stored config-
urations. The trajectories were analyzed using GROMACS (Van Der Spoel et al., 2005) and Visual Molecular Dynamics (VMD) (Hum-
phrey et al., 1996).
QUANTIFICATION AND STATISTICAL ANALYSIS
Statistical details of each experiment can be found in the figure legends. For bothwestern blot andDNA gel images, Quantity One 1-D
Analysis Software (Bio-Rad) was used to quantify the intensities of bands. The value of n is specified for each figure in the legend as
well as the p value when statistical test was performed. For FRET assays, the ‘‘n’’ value represents the experimental replicates. For
TOXCAT assays and in vivo experiments, the ‘‘n’’ value represents biological replicates (different passages of cells). To compare two
groups, statistical analyzes using Student’s t test along with normality test (Shapiro-Wilk) were conducted in SigmaPlot software.Cell Reports 27, 307–320.e1–e5, April 2, 2019 e5
